1
|
Gomaa AI, Khan SA, Toledano MB, Waked I
and Taylor-Robinson SD: Hepatocellular carcinoma: Epidemiology,
risk factors and pathogenesis. World J Gastroenterol. 14:4300–4308.
2008. View Article : Google Scholar : PubMed/NCBI
|
2
|
Lim SG, Mohammed R, Yuen MF and Kao JH:
Prevention of hepatocellular carcinoma in hepatitis B virus
infection. J Gastroenterol Hepatol. 24:1352–1357. 2009. View Article : Google Scholar : PubMed/NCBI
|
3
|
Kim BK, Han KH and Ahn SH: Prevention of
hepatocellular carcinoma in patients with chronic hepatitis B virus
infection. Oncology. 81(Suppl 1): 41–49. 2011. View Article : Google Scholar
|
4
|
Nguyen VT, Law MG and Dore GJ: Hepatitis
B-related hepatocellular carcinoma: epidemiological characteristics
and disease burden. J Viral Hepat. 16:453–463. 2009. View Article : Google Scholar : PubMed/NCBI
|
5
|
Su CH, Lin Y and Cai L: Genetic factors,
viral infection, other factors and liver cancer: an update on
current progress. Asian Pac J Cancer Prev. 14:4953–4960. 2013.
View Article : Google Scholar : PubMed/NCBI
|
6
|
Cougot D, Neuveut C and Buendia MA: HBV
induced carcinogenesis. J Clin Virol. 34(Suppl 1): 75–78. 2005.
View Article : Google Scholar
|
7
|
Zhang R, Cao Y, Bai L, et al: The collagen
triple helix repeat containing 1 facilitates hepatitis B
virus-associated hepatocellular carcinoma progression by regulating
multiple cellular factors and signal cascades. Mol Carcinog. Sep
27–2014.Epub a head of print. View
Article : Google Scholar
|
8
|
Martinez NW, Xue X, Berro RG, Kreitzer G
and Resh MD: Kinesin KIF4 regulates intracellular trafficking and
stability of the human immunodeficiency virus type 1 Gag
polyprotein. J Virol. 82:9937–9950. 2008. View Article : Google Scholar : PubMed/NCBI
|
9
|
Wu G and Chen PL: Structural requirements
of chromokinesin Kif4A for its proper function in mitosis. Biochem
Biophys Res Commun. 372:454–458. 2008. View Article : Google Scholar : PubMed/NCBI
|
10
|
Ha MJ, Yoon J, Moon E, Lee YM, Kim HJ and
Kim W: Assignment of the kinesin family member 4 genes (KIF4A and
KIF4B) to human chromosome bands Xq13.1 and 5q33.1 by in situ
hybridization. Cytogenet Cell Genet. 88:41–42. 2000. View Article : Google Scholar : PubMed/NCBI
|
11
|
Taniwaki M, Takano A, Ishikawa N, et al:
Activation of KIF4A as a prognostic biomarker and therapeutic
target for lung cancer. Clin Cancer Res. 13:6624–6631. 2007.
View Article : Google Scholar : PubMed/NCBI
|
12
|
Wu G, Zhou L, Khidr L, et al: A novel role
of the chromokinesin Kif4A in DNA damage response. Cell Cycle.
7:2013–2020. 2008. View Article : Google Scholar : PubMed/NCBI
|
13
|
Nunes Bastos R, Gandhi SR, Baron RD,
Gruneberg U, Nigg EA and Barr FA: Aurora B suppresses microtubule
dynamics and limits central spindle size by locally activating
KIF4A. J Cell Biol. 202:605–621. 2013. View Article : Google Scholar : PubMed/NCBI
|
14
|
Tan YJ: Hepatitis B virus infection and
the risk of hepatocellular carcinoma. World J Gastroenterol.
17:4853–4857. 2011. View Article : Google Scholar : PubMed/NCBI
|
15
|
Zhu C, Zhang R, Liu L, et al: Hepatitis B
virus enhances interleukin-27 expression both in vivo and in vitro.
Clin Immunol. 131:92–97. 2009. View Article : Google Scholar
|
16
|
Li Y, Xie J, Xu X, et al: Inducible
interleukin 32 (IL-32) exerts extensive antiviral function via
selective stimulation of interferon lambda1 (IFN-lambda1). J Biol
Chem. 288:20927–20941. 2013. View Article : Google Scholar : PubMed/NCBI
|
17
|
Lu L, Wei L, Peng G, et al: NS3 protein of
hepatitis C virus regulates cyclooxygenase-2 expression through
multiple signaling pathways. Virology. 371:61–70. 2008. View Article : Google Scholar
|
18
|
Lee YM and Kim W: Association of human
kinesin superfamily protein member 4 with BRCA2-associated factor
35. Biochem J. 374:497–503. 2003. View Article : Google Scholar : PubMed/NCBI
|
19
|
Gao J, Sai N, Wang C, et al:
Overexpression of chromokinesin KIF4 inhibits proliferation of
human gastric carcinoma cells both in vitro and in vivo. Tumour
Biol. 32:53–61. 2011. View Article : Google Scholar
|
20
|
Narayan G, Bourdon V, Chaganti S, et al:
Gene dosage alterations revealed by cDNA microarray analysis in
cervical cancer: identification of candidate amplified and
overexpressed genes. Genes Chromosomes Cancer. 46:373–384. 2007.
View Article : Google Scholar : PubMed/NCBI
|